Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. [electronic resource]
Producer: 20000518Description: 1652-61 p. digitalISSN:- 0732-183X
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Cisplatin -- administration & dosage
- Combined Modality Therapy
- Disease Progression
- Female
- Fluorouracil -- administration & dosage
- Head and Neck Neoplasms -- drug therapy
- Humans
- Hydroxyurea -- administration & dosage
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Male
- Quality of Life
- Radiotherapy -- adverse effects
- Radiotherapy Dosage
- Recombinant Proteins
- Survival Rate
- Tretinoin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.